Clinical trials data

Affective Go/No-Go in clinical trials: 48 registered studies

Every registered study on ClinicalTrials.gov that names Affective Go/No-Go in an outcome measure: the conditions it is used in, how often it is a primary outcome, the tests it is named with, and how large the studies are.

Registered studies name it in an outcome measure: 48
Name it in a primary outcome, 38%: 18 of 48; Against similar tests
Of studies started 2021 to 2025 name it, against 0.3% in 2016 to 2020: 0.2%; By year
Median participants per study: 67; By phase

Try Affective Go/No-Go

The conditions it is used in

Each study counted once in each condition group it falls in.

Depression and bipolar disorder19 studies, 7 as a primary outcome
Anxiety, PTSD and OCD9 studies, 2 as a primary outcome
Healthy volunteers6 studies, 4 as a primary outcome
ADHD3 studies, 1 as a primary outcome
Substance use and addiction3 studies, 1 as a primary outcome
Schizophrenia and psychosis2 studies, 0 as a primary outcome
Obesity and diabetes2 studies, 0 as a primary outcome
Epilepsy2 studies, 1 as a primary outcome
Pain and fatigue1 study, 1 as a primary outcome
Other conditions10 studies, 4 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

How often it is a primary outcome

Affective Go/No-Go is a primary outcome in 38% of its studies. Across the 4 response inhibition tests with a page here, the median is 45%.

Antisaccade Task60% of 68 studies
Stop-Signal Task46% of 321 studies
Go/No-Go Task44% of 702 studies
Affective Go/No-Go38% of 48 studies

Studies by start year

0.2% of the registered studies that started in 2021 to 2025 name it, against 0.3% of those that started in 2016 to 2020. 2026 is partly planned starts.

A test as a primary outcomeOnly in secondary or other outcomes

Show as a table

Registered studies by start year
Start year	Studies	A test as a primary outcome
2000	0	0
2001	0	0
2002	0	0
2003	0	0
2004	0	0
2005	0	0
2006	0	0
2007	0	0
2008	0	0
2009	0	0
2010	2	1
2011	0	0
2012	1	0
2013	3	0
2014	2	0
2015	5	4
2016	6	3
2017	3	1
2018	2	0
2019	1	1
2020	2	1
2021	1	0
2022	2	1
2023	5	2
2024	4	1
2025	5	2
2026	3	0

Phases and study sizes

By phase

Early phase 11 studies, 1 as a primary outcome
Phase 1/21 studies, 0 as a primary outcome
Phase 24 studies, 3 as a primary outcome
Phase 32 studies, 0 as a primary outcome
Phase 42 studies, 1 as a primary outcome
Not applicable29 studies, 10 as a primary outcome
Observational9 studies, 3 as a primary outcome

Participants per study

Not applicable64 median, 28 to 98

Participants per study. The bar spans the middle half of the studies in each phase, the mark is the median, and the axis is logarithmic. Phases with fewer than 10 studies that give a size are left out.

Show as a table

Participants per study that names Affective Go/No-Go, by phase
Phase	Studies with a size	Median	Middle half
Not applicable	29	64	28 to 98

When trials measure it

Half of the primary outcomes that name Affective Go/No-Go are measured within 9 weeks of the start, and the middle half from 4 days to 5 months. 18 primary outcomes give a duration.

Latest time point of each outcome

Within a day13 outcomes, 5 as a primary outcome
Up to 4 weeks11 outcomes, 2 as a primary outcome
1 to 3 months12 outcomes, 5 as a primary outcome
3 to 6 months5 outcomes, 3 as a primary outcome
6 to 12 months3 outcomes, 2 as a primary outcome
1 to 2 years2 outcomes, 1 as a primary outcome
No duration given2 outcomes, 0 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

46 of the 48 outcome measures give a duration. A single visit counts as within a day.

Status, results, interventions and countries

Status

Recruiting8 studies, 2 as a primary outcome
Not yet recruiting2 studies, 1 as a primary outcome
Active, not recruiting2 studies, 2 as a primary outcome
Completed28 studies, 10 as a primary outcome
Stopped early1 studies, 1 as a primary outcome
Status unknown7 studies, 2 as a primary outcome

What they test

Behavioral17 studies, 8 as a primary outcome
Drug15 studies, 5 as a primary outcome
Device5 studies, 3 as a primary outcome
Dietary supplement4 studies, 1 as a primary outcome
Other13 studies, 6 as a primary outcome
None given3 studies, 0 as a primary outcome

Intervention types as registered. A study can list several; observational studies often list none.

11 countries in all. A study with sites in several counts in each; 0 list no site.

Reported results

Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.

Completed studies that name Affective Go/No-Go: 7 of 28, 25%

Every completed study with a cognitive outcome: 3,626 of 7,953, 46%

Completed studies that name Affective Go/No-Go and every completed study, by how they reported results
Results	Completed studies that name Affective Go/No-Go	Every completed study
Results on ClinicalTrials.gov and a paper	2, 7%	776, 10%
Results on ClinicalTrials.gov only	3, 11%	1,139, 14%
A results paper only	2, 7%	1,711, 22%
Neither	21, 75%	4,327, 54%

Tests named in the same studies

The library tests that studies naming Affective Go/No-Go name most often beside it.

1
Go/No-Go Task48 studies, 19 as a primary outcome
2
N-Back Task8 studies, 2 as a primary outcome
3
Verbal Learning6 studies, 1 as a primary outcome
4
Probabilistic Reversal Learning5 studies, 2 as a primary outcome
5
Digit Span Test5 studies, 0 as a primary outcome
6
Card Sorting Test (Berg)4 studies, 1 as a primary outcome
7
Emotional Stroop Task4 studies, 1 as a primary outcome
8
Stop-Signal Task4 studies, 1 as a primary outcome
9
Continuous Performance Test3 studies, 2 as a primary outcome
10
Emotion Regulation Task3 studies, 2 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

Compared over time

Studies per start year for Affective Go/No-Go and the tests named with it most. Add or remove tests to compare.

Add a test

Affective Go/No-Go47 studies, 2000 to 2026

Go/No-Go Task699 studies, 2000 to 2026

N-Back Task787 studies, 2000 to 2026

Verbal Learning1,819 studies, 2000 to 2026

The panel's testThe other tests chosenEvery panel has the same scale. 2026 is partly planned starts.

Show as a table

Registered studies per start year that name each test
Start year	Affective Go/No-Go	Go/No-Go Task	N-Back Task	Verbal Learning
2000	0	0	0	1
2001	0	1	0	5
2002	0	2	2	8
2003	0	1	2	14
2004	0	2	0	14
2005	0	0	4	17
2006	0	1	3	13
2007	0	1	10	22
2008	0	4	10	28
2009	0	5	5	28
2010	2	8	11	42
2011	0	13	20	33
2012	1	13	14	42
2013	3	19	23	53
2014	2	22	25	82
2015	5	24	25	91
2016	6	34	32	98
2017	3	37	51	107
2018	2	40	54	92
2019	1	46	59	122
2020	2	32	30	76
2021	1	62	70	137
2022	2	60	62	138
2023	5	67	71	157
2024	4	64	69	144
2025	5	77	67	132
2026	3	64	68	123

Explore the 48 studies

Filter by condition, phase, sponsor, status, country, intervention, outcome list, size and start year. Each study links to its record on ClinicalTrials.gov.

48 studies match. 18 name Affective Go/No-Go in a primary outcome. Median size 67 participants. Median time to the primary outcome: 9 weeks.

Loading 48 studies; the filters turn on when they arrive.

By start year

2026 is partly planned starts. Not shown: 1 planned to start after 2026.

Show as a table

Matching studies by start year
Start year	Studies	As a primary outcome
2000	0	0
2001	0	0
2002	0	0
2003	0	0
2004	0	0
2005	0	0
2006	0	0
2007	0	0
2008	0	0
2009	0	0
2010	2	1
2011	0	0
2012	1	0
2013	3	0
2014	2	0
2015	5	4
2016	6	3
2017	3	1
2018	2	0
2019	1	1
2020	2	1
2021	1	0
2022	2	1
2023	5	2
2024	4	1
2025	5	2
2026	3	0

Library tests named most

Conditions

Phases

Participants

Lead sponsor: industry 3, other 45. Interventional 39, observational 9.

As a primary outcomeSecondary or other outcomeAffective Go/No-Go

The studies, newest registration first

Each number opens the study's record on ClinicalTrials.gov.

Registered studies that match the filters, newest registration first, with the library tests each one names and the outcome list that names them.
Study	Start	Phase	Conditions	Participants	Lead sponsor	Status	Library tests named, with the latest time point
NCT07848477	Start2026	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants60	Lead sponsorOther	StatusRecruiting	Library tests named Verbal LearningPrimary2 weeks Digit Span TestSecondary2 weeks Symbol CodingSecondary2 weeks N-Back TaskSecondary2 weeks Go/No-Go TaskSecondary2 weeks Paired Associate LearningSecondary2 weeks Probabilistic Reversal LearningSecondary2 weeks Mnemonic Similarity TaskSecondary2 weeks Affective Go/No-GoSecondary2 weeks Grid Pattern Span TaskSecondary2 weeks
NCT07845409	Start2027	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants138	Lead sponsorOther	StatusNot yet recruiting	Library tests named Trail Making TestPrimary10 weeks Go/No-Go TaskPrimary10 weeks Continuous Performance TestPrimary10 weeks AX Continuous Performance TestPrimary10 weeks Monetary Incentive DelayPrimary10 weeks Affective Go/No-GoPrimary10 weeks
NCT07771595	Start2026	PhasePhase 4	ConditionsOther conditions	Participants40	Lead sponsorOther	StatusNot yet recruiting	Library tests named Go/No-Go TaskSecondarysame day Affective Go/No-GoSecondarysame day Effort Discounting TaskSecondarysame day
NCT07590999	Start2025	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants106	Lead sponsorOther	StatusRecruiting	Library tests named Verbal LearningSecondary9 weeks Digit Span TestSecondary9 weeks N-Back TaskSecondary9 weeks Go/No-Go TaskSecondary9 weeks Probabilistic Reversal LearningSecondary9 weeks Affective Go/No-GoSecondary9 weeks
NCT07477470	Start2026	PhaseNot applicable	ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD	Participants120	Lead sponsorIndustry	StatusRecruiting	Library tests named N-Back TaskSecondary12 weeks Go/No-Go TaskSecondary12 weeks Task Switching TestSecondary12 weeks Attention Network TestSecondary12 weeks Affective Go/No-GoSecondary12 weeks
NCT07267559	Start2025	PhasePhase 4	ConditionsOther conditions	Participants62	Lead sponsorOther	StatusRecruiting	Library tests named Go/No-Go TaskPrimarysame day Emoji Emotion RecognitionSecondarysame day Affective Go/No-GoPrimarysame day Swap Spotter Game and Change DetectionSecondarysame day
NCT07201909	Start2025	PhaseNot applicable	ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD	Participants156	Lead sponsorIndustry	StatusRecruiting	Library tests named N-Back TaskSecondary12 weeks Go/No-Go TaskSecondary12 weeks Task Switching TestSecondary12 weeks Attention Network TestSecondary12 weeks Emotional Stroop TaskSecondary12 weeks Affective Go/No-GoSecondary12 weeks
NCT07183748	Start2025	PhasePhase 2	ConditionsDepression and bipolar disorder	Participants20	Lead sponsorOther	StatusRecruiting	Library tests named Go/No-Go TaskPrimary6 months Task Switching TestPrimary6 months Affective Go/No-GoPrimary6 months Associative Recognition TestPrimary6 months
NCT07036055	Start2024	PhaseNot applicable	ConditionsSubstance use and addiction	Participants60	Lead sponsorOther	StatusCompleted	Library tests named Go/No-Go TaskPrimary2 weeks Affective Go/No-GoPrimary2 weeks
NCT07022366	Start2025	PhaseNot applicable	ConditionsHealthy volunteers	Participants80	Lead sponsorOther	StatusRecruiting	Library tests named Go/No-Go TaskSecondarysame day Card Sorting Test (Berg)Secondarysame day Probabilistic Reversal LearningPrimarysame day Affective Go/No-GoSecondarysame day
NCT06647056	Start2024	PhaseNot applicable	ConditionsEpilepsy	Participants4	Lead sponsorOther	StatusCompleted	Library tests named Go/No-Go TaskPrimary3 days Affective Go/No-GoSecondary3 days
NCT06557642	Start2024	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants88	Lead sponsorOther	StatusRecruiting	Library tests named Go/No-Go TaskSecondarysame day Probabilistic Reversal LearningSecondarysame day Affective Go/No-GoSecondarysame day
NCT06363487	Start2024	PhaseNot applicable	ConditionsOther conditions	Participants70	Lead sponsorOther	StatusCompleted	Library tests named N-Back TaskSecondary1 week Go/No-Go TaskSecondary1 week Affective Go/No-GoSecondary1 week
NCT06063642	Start2023	PhaseNot applicable	ConditionsSubstance use and addiction	Participants20	Lead sponsorOther	StatusCompleted Paper	Library tests named Go/No-Go TaskSecondary3 days Cue Reactivity TaskSecondary3 days Affective Go/No-GoSecondary3 days
NCT05966532	Start2023	PhaseObservational	ConditionsDepression and bipolar disorder, Healthy volunteers	Participants276	Lead sponsorOther	StatusActive, not recruiting	Library tests named Verbal LearningSecondarysame day Verbal FluencySecondarysame day Go/No-Go TaskPrimarysame day Category FluencySecondarysame day Affective Go/No-GoPrimarysame day Betting Choice TaskPrimarysame day
NCT05585775	Start2023	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants64	Lead sponsorOther	StatusCompleted	Library tests named N-Back TaskPrimary10 weeks Go/No-Go TaskPrimary10 weeks Affective Go/No-GoPrimary10 weeks
NCT05487534	Start2023	PhaseObservational	ConditionsObesity and diabetes	Participants150	Lead sponsorOther	StatusStatus unknown	Library tests named Go/No-Go TaskSecondary1 week Stop-Signal TaskSecondary4 days Delay DiscountingSecondary4 days Tower PlanningSecondary4 days Affective Go/No-GoSecondary1 week
NCT05468385	Start2022	PhaseNot applicable	ConditionsHealthy volunteers	Participants90	Lead sponsorOther	StatusCompleted	Library tests named Go/No-Go TaskPrimarysame day Affective Go/No-GoPrimarysame day
NCT05220228	Start2022	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants50	Lead sponsorOther	StatusCompleted	Library tests named N-Back TaskPrimary1 week Go/No-Go TaskSecondary Affective Go/No-GoSecondary Word Valence Memory TaskSecondary
NCT05149859	Start2023	PhaseObservational	ConditionsObesity and diabetes	Participants200	Lead sponsorOther	StatusStatus unknown	Library tests named Go/No-Go TaskSecondary Continuous Performance TestSecondary Stop-Signal TaskSecondary Affective Go/No-GoSecondary
NCT04851704	Start2016	PhaseNot applicable	ConditionsOther conditions	Participants79	Lead sponsorOther	StatusActive, not recruiting	Library tests named Go/No-Go TaskPrimary6 months Continuous Performance TestPrimary6 months AX Continuous Performance TestPrimary6 months Affective Go/No-GoPrimary6 months
NCT04490265	Start2020	PhaseNot applicable	ConditionsPain and fatigue	Participants60	Lead sponsorOther	StatusCompleted Results	Library tests named Go/No-Go TaskPrimary12 weeks Iowa Gambling LitePrimary12 weeks Emotional Stroop TaskPrimary12 weeks Affective Go/No-GoPrimary12 weeks
NCT04424745	Start2021	PhaseNot applicable	ConditionsOther conditions	Participants84	Lead sponsorOther	StatusCompleted	Library tests named N-Back TaskSecondary3 weeks Go/No-Go TaskSecondary3 weeks Card Sorting Test (Berg)Secondary3 weeks Dot-Probe TaskSecondary8 weeks Attention Network TestSecondary8 weeks Affective Go/No-GoSecondary3 weeks
NCT03979404	Start2020	PhaseNot applicable	ConditionsOther conditions	Participants15	Lead sponsorOther	StatusStatus unknown	Library tests named Go/No-Go TaskSecondary4 weeks Dot-Probe TaskSecondary4 weeks Emotion Regulation TaskSecondary4 weeks Affective Go/No-GoSecondary4 weeks Food Choice TaskSecondary4 weeks
NCT03869463	Start2019	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants28	Lead sponsorOther	StatusStopped early	Library tests named Trail Making TestPrimary13 weeks Verbal LearningOther outcome13 weeks Verbal FluencyOther outcome13 weeks Digit Span TestOther outcome13 weeks Go/No-Go TaskPrimary8 weeks Symbol Scan TaskOther outcome13 weeks Affective Go/No-GoPrimary8 weeks

Questions, answered from the data

How many clinical trials use Affective Go/No-Go?

48 registered studies on ClinicalTrials.gov name it in an outcome measure, 18 of them in a primary outcome.

In which conditions do trials use Affective Go/No-Go?

Most often in depression and bipolar disorder (19), anxiety, PTSD and OCD (9) and healthy volunteers (6).

Do new trials use Affective Go/No-Go more or less?

0.2% of the studies that started in 2021 to 2025 name it, against 0.3% of those that started in 2016 to 2020: a share 23% smaller.

Which tests do trials use with Affective Go/No-Go?

The Go/No-Go Task (48 studies), the N-Back Task (8 studies) and Verbal Learning (6 studies).

When do trials measure Affective Go/No-Go?

Half of the primary outcomes that name Affective Go/No-Go are measured within 9 weeks of the start, and the middle half from 4 days to 5 months. 18 primary outcomes give a duration.

How many completed trials that use Affective Go/No-Go have reported results?

7 of the 28 completed studies that name it, 25%, have reported results: 5 posted them on ClinicalTrials.gov, 4 have a results paper linked to the registry record, and 2 did both. The other 21 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.

How the studies are counted

For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.

The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.

A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.

A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.

Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.

Run Affective Go/No-Go in your trial

Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.

Start free

Clinical trials data

Affective Go/No-Go in clinical trials: 48 registered studies

Registered studies name it in an outcome measure: 48
Name it in a primary outcome, 38%: 18 of 48; Against similar tests
Of studies started 2021 to 2025 name it, against 0.3% in 2016 to 2020: 0.2%; By year
Median participants per study: 67; By phase

Try Affective Go/No-Go

The conditions it is used in

Each study counted once in each condition group it falls in.

Depression and bipolar disorder19 studies, 7 as a primary outcome
Anxiety, PTSD and OCD9 studies, 2 as a primary outcome
Healthy volunteers6 studies, 4 as a primary outcome
ADHD3 studies, 1 as a primary outcome
Substance use and addiction3 studies, 1 as a primary outcome
Schizophrenia and psychosis2 studies, 0 as a primary outcome
Obesity and diabetes2 studies, 0 as a primary outcome
Epilepsy2 studies, 1 as a primary outcome
Pain and fatigue1 study, 1 as a primary outcome
Other conditions10 studies, 4 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

How often it is a primary outcome

Affective Go/No-Go is a primary outcome in 38% of its studies. Across the 4 response inhibition tests with a page here, the median is 45%.

Antisaccade Task60% of 68 studies
Stop-Signal Task46% of 321 studies
Go/No-Go Task44% of 702 studies
Affective Go/No-Go38% of 48 studies

Studies by start year

0.2% of the registered studies that started in 2021 to 2025 name it, against 0.3% of those that started in 2016 to 2020. 2026 is partly planned starts.

A test as a primary outcomeOnly in secondary or other outcomes

Show as a table

Registered studies by start year
Start year	Studies	A test as a primary outcome
2000	0	0
2001	0	0
2002	0	0
2003	0	0
2004	0	0
2005	0	0
2006	0	0
2007	0	0
2008	0	0
2009	0	0
2010	2	1
2011	0	0
2012	1	0
2013	3	0
2014	2	0
2015	5	4
2016	6	3
2017	3	1
2018	2	0
2019	1	1
2020	2	1
2021	1	0
2022	2	1
2023	5	2
2024	4	1
2025	5	2
2026	3	0

Phases and study sizes

By phase

Early phase 11 studies, 1 as a primary outcome
Phase 1/21 studies, 0 as a primary outcome
Phase 24 studies, 3 as a primary outcome
Phase 32 studies, 0 as a primary outcome
Phase 42 studies, 1 as a primary outcome
Not applicable29 studies, 10 as a primary outcome
Observational9 studies, 3 as a primary outcome

Participants per study

Not applicable64 median, 28 to 98

Show as a table

Participants per study that names Affective Go/No-Go, by phase
Phase	Studies with a size	Median	Middle half
Not applicable	29	64	28 to 98

When trials measure it

Half of the primary outcomes that name Affective Go/No-Go are measured within 9 weeks of the start, and the middle half from 4 days to 5 months. 18 primary outcomes give a duration.

Latest time point of each outcome

Within a day13 outcomes, 5 as a primary outcome
Up to 4 weeks11 outcomes, 2 as a primary outcome
1 to 3 months12 outcomes, 5 as a primary outcome
3 to 6 months5 outcomes, 3 as a primary outcome
6 to 12 months3 outcomes, 2 as a primary outcome
1 to 2 years2 outcomes, 1 as a primary outcome
No duration given2 outcomes, 0 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

46 of the 48 outcome measures give a duration. A single visit counts as within a day.

Status, results, interventions and countries

Status

Recruiting8 studies, 2 as a primary outcome
Not yet recruiting2 studies, 1 as a primary outcome
Active, not recruiting2 studies, 2 as a primary outcome
Completed28 studies, 10 as a primary outcome
Stopped early1 studies, 1 as a primary outcome
Status unknown7 studies, 2 as a primary outcome

What they test

Behavioral17 studies, 8 as a primary outcome
Drug15 studies, 5 as a primary outcome
Device5 studies, 3 as a primary outcome
Dietary supplement4 studies, 1 as a primary outcome
Other13 studies, 6 as a primary outcome
None given3 studies, 0 as a primary outcome

Intervention types as registered. A study can list several; observational studies often list none.

11 countries in all. A study with sites in several counts in each; 0 list no site.

Reported results

Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.

Completed studies that name Affective Go/No-Go: 7 of 28, 25%

Every completed study with a cognitive outcome: 3,626 of 7,953, 46%

Completed studies that name Affective Go/No-Go and every completed study, by how they reported results
Results	Completed studies that name Affective Go/No-Go	Every completed study
Results on ClinicalTrials.gov and a paper	2, 7%	776, 10%
Results on ClinicalTrials.gov only	3, 11%	1,139, 14%
A results paper only	2, 7%	1,711, 22%
Neither	21, 75%	4,327, 54%

Tests named in the same studies

The library tests that studies naming Affective Go/No-Go name most often beside it.

1
Go/No-Go Task48 studies, 19 as a primary outcome
2
N-Back Task8 studies, 2 as a primary outcome
3
Verbal Learning6 studies, 1 as a primary outcome
4
Probabilistic Reversal Learning5 studies, 2 as a primary outcome
5
Digit Span Test5 studies, 0 as a primary outcome
6
Card Sorting Test (Berg)4 studies, 1 as a primary outcome
7
Emotional Stroop Task4 studies, 1 as a primary outcome
8
Stop-Signal Task4 studies, 1 as a primary outcome
9
Continuous Performance Test3 studies, 2 as a primary outcome
10
Emotion Regulation Task3 studies, 2 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

Compared over time

Studies per start year for Affective Go/No-Go and the tests named with it most. Add or remove tests to compare.

Add a test

Affective Go/No-Go47 studies, 2000 to 2026

Go/No-Go Task699 studies, 2000 to 2026

N-Back Task787 studies, 2000 to 2026

Verbal Learning1,819 studies, 2000 to 2026

The panel's testThe other tests chosenEvery panel has the same scale. 2026 is partly planned starts.

Show as a table

Registered studies per start year that name each test
Start year	Affective Go/No-Go	Go/No-Go Task	N-Back Task	Verbal Learning
2000	0	0	0	1
2001	0	1	0	5
2002	0	2	2	8
2003	0	1	2	14
2004	0	2	0	14
2005	0	0	4	17
2006	0	1	3	13
2007	0	1	10	22
2008	0	4	10	28
2009	0	5	5	28
2010	2	8	11	42
2011	0	13	20	33
2012	1	13	14	42
2013	3	19	23	53
2014	2	22	25	82
2015	5	24	25	91
2016	6	34	32	98
2017	3	37	51	107
2018	2	40	54	92
2019	1	46	59	122
2020	2	32	30	76
2021	1	62	70	137
2022	2	60	62	138
2023	5	67	71	157
2024	4	64	69	144
2025	5	77	67	132
2026	3	64	68	123

Explore the 48 studies

Filter by condition, phase, sponsor, status, country, intervention, outcome list, size and start year. Each study links to its record on ClinicalTrials.gov.

48 studies match. 18 name Affective Go/No-Go in a primary outcome. Median size 67 participants. Median time to the primary outcome: 9 weeks.

Loading 48 studies; the filters turn on when they arrive.

By start year

2026 is partly planned starts. Not shown: 1 planned to start after 2026.

Show as a table

Matching studies by start year
Start year	Studies	As a primary outcome
2000	0	0
2001	0	0
2002	0	0
2003	0	0
2004	0	0
2005	0	0
2006	0	0
2007	0	0
2008	0	0
2009	0	0
2010	2	1
2011	0	0
2012	1	0
2013	3	0
2014	2	0
2015	5	4
2016	6	3
2017	3	1
2018	2	0
2019	1	1
2020	2	1
2021	1	0
2022	2	1
2023	5	2
2024	4	1
2025	5	2
2026	3	0

Library tests named most

Conditions

Phases

Participants

Lead sponsor: industry 3, other 45. Interventional 39, observational 9.

As a primary outcomeSecondary or other outcomeAffective Go/No-Go

The studies, newest registration first

Each number opens the study's record on ClinicalTrials.gov.

Registered studies that match the filters, newest registration first, with the library tests each one names and the outcome list that names them.
Study	Start	Phase	Conditions	Participants	Lead sponsor	Status	Library tests named, with the latest time point
NCT07848477	Start2026	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants60	Lead sponsorOther	StatusRecruiting	Library tests named Verbal LearningPrimary2 weeks Digit Span TestSecondary2 weeks Symbol CodingSecondary2 weeks N-Back TaskSecondary2 weeks Go/No-Go TaskSecondary2 weeks Paired Associate LearningSecondary2 weeks Probabilistic Reversal LearningSecondary2 weeks Mnemonic Similarity TaskSecondary2 weeks Affective Go/No-GoSecondary2 weeks Grid Pattern Span TaskSecondary2 weeks
NCT07845409	Start2027	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants138	Lead sponsorOther	StatusNot yet recruiting	Library tests named Trail Making TestPrimary10 weeks Go/No-Go TaskPrimary10 weeks Continuous Performance TestPrimary10 weeks AX Continuous Performance TestPrimary10 weeks Monetary Incentive DelayPrimary10 weeks Affective Go/No-GoPrimary10 weeks
NCT07771595	Start2026	PhasePhase 4	ConditionsOther conditions	Participants40	Lead sponsorOther	StatusNot yet recruiting	Library tests named Go/No-Go TaskSecondarysame day Affective Go/No-GoSecondarysame day Effort Discounting TaskSecondarysame day
NCT07590999	Start2025	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants106	Lead sponsorOther	StatusRecruiting	Library tests named Verbal LearningSecondary9 weeks Digit Span TestSecondary9 weeks N-Back TaskSecondary9 weeks Go/No-Go TaskSecondary9 weeks Probabilistic Reversal LearningSecondary9 weeks Affective Go/No-GoSecondary9 weeks
NCT07477470	Start2026	PhaseNot applicable	ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD	Participants120	Lead sponsorIndustry	StatusRecruiting	Library tests named N-Back TaskSecondary12 weeks Go/No-Go TaskSecondary12 weeks Task Switching TestSecondary12 weeks Attention Network TestSecondary12 weeks Affective Go/No-GoSecondary12 weeks
NCT07267559	Start2025	PhasePhase 4	ConditionsOther conditions	Participants62	Lead sponsorOther	StatusRecruiting	Library tests named Go/No-Go TaskPrimarysame day Emoji Emotion RecognitionSecondarysame day Affective Go/No-GoPrimarysame day Swap Spotter Game and Change DetectionSecondarysame day
NCT07201909	Start2025	PhaseNot applicable	ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD	Participants156	Lead sponsorIndustry	StatusRecruiting	Library tests named N-Back TaskSecondary12 weeks Go/No-Go TaskSecondary12 weeks Task Switching TestSecondary12 weeks Attention Network TestSecondary12 weeks Emotional Stroop TaskSecondary12 weeks Affective Go/No-GoSecondary12 weeks
NCT07183748	Start2025	PhasePhase 2	ConditionsDepression and bipolar disorder	Participants20	Lead sponsorOther	StatusRecruiting	Library tests named Go/No-Go TaskPrimary6 months Task Switching TestPrimary6 months Affective Go/No-GoPrimary6 months Associative Recognition TestPrimary6 months
NCT07036055	Start2024	PhaseNot applicable	ConditionsSubstance use and addiction	Participants60	Lead sponsorOther	StatusCompleted	Library tests named Go/No-Go TaskPrimary2 weeks Affective Go/No-GoPrimary2 weeks
NCT07022366	Start2025	PhaseNot applicable	ConditionsHealthy volunteers	Participants80	Lead sponsorOther	StatusRecruiting	Library tests named Go/No-Go TaskSecondarysame day Card Sorting Test (Berg)Secondarysame day Probabilistic Reversal LearningPrimarysame day Affective Go/No-GoSecondarysame day
NCT06647056	Start2024	PhaseNot applicable	ConditionsEpilepsy	Participants4	Lead sponsorOther	StatusCompleted	Library tests named Go/No-Go TaskPrimary3 days Affective Go/No-GoSecondary3 days
NCT06557642	Start2024	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants88	Lead sponsorOther	StatusRecruiting	Library tests named Go/No-Go TaskSecondarysame day Probabilistic Reversal LearningSecondarysame day Affective Go/No-GoSecondarysame day
NCT06363487	Start2024	PhaseNot applicable	ConditionsOther conditions	Participants70	Lead sponsorOther	StatusCompleted	Library tests named N-Back TaskSecondary1 week Go/No-Go TaskSecondary1 week Affective Go/No-GoSecondary1 week
NCT06063642	Start2023	PhaseNot applicable	ConditionsSubstance use and addiction	Participants20	Lead sponsorOther	StatusCompleted Paper	Library tests named Go/No-Go TaskSecondary3 days Cue Reactivity TaskSecondary3 days Affective Go/No-GoSecondary3 days
NCT05966532	Start2023	PhaseObservational	ConditionsDepression and bipolar disorder, Healthy volunteers	Participants276	Lead sponsorOther	StatusActive, not recruiting	Library tests named Verbal LearningSecondarysame day Verbal FluencySecondarysame day Go/No-Go TaskPrimarysame day Category FluencySecondarysame day Affective Go/No-GoPrimarysame day Betting Choice TaskPrimarysame day
NCT05585775	Start2023	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants64	Lead sponsorOther	StatusCompleted	Library tests named N-Back TaskPrimary10 weeks Go/No-Go TaskPrimary10 weeks Affective Go/No-GoPrimary10 weeks
NCT05487534	Start2023	PhaseObservational	ConditionsObesity and diabetes	Participants150	Lead sponsorOther	StatusStatus unknown	Library tests named Go/No-Go TaskSecondary1 week Stop-Signal TaskSecondary4 days Delay DiscountingSecondary4 days Tower PlanningSecondary4 days Affective Go/No-GoSecondary1 week
NCT05468385	Start2022	PhaseNot applicable	ConditionsHealthy volunteers	Participants90	Lead sponsorOther	StatusCompleted	Library tests named Go/No-Go TaskPrimarysame day Affective Go/No-GoPrimarysame day
NCT05220228	Start2022	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants50	Lead sponsorOther	StatusCompleted	Library tests named N-Back TaskPrimary1 week Go/No-Go TaskSecondary Affective Go/No-GoSecondary Word Valence Memory TaskSecondary
NCT05149859	Start2023	PhaseObservational	ConditionsObesity and diabetes	Participants200	Lead sponsorOther	StatusStatus unknown	Library tests named Go/No-Go TaskSecondary Continuous Performance TestSecondary Stop-Signal TaskSecondary Affective Go/No-GoSecondary
NCT04851704	Start2016	PhaseNot applicable	ConditionsOther conditions	Participants79	Lead sponsorOther	StatusActive, not recruiting	Library tests named Go/No-Go TaskPrimary6 months Continuous Performance TestPrimary6 months AX Continuous Performance TestPrimary6 months Affective Go/No-GoPrimary6 months
NCT04490265	Start2020	PhaseNot applicable	ConditionsPain and fatigue	Participants60	Lead sponsorOther	StatusCompleted Results	Library tests named Go/No-Go TaskPrimary12 weeks Iowa Gambling LitePrimary12 weeks Emotional Stroop TaskPrimary12 weeks Affective Go/No-GoPrimary12 weeks
NCT04424745	Start2021	PhaseNot applicable	ConditionsOther conditions	Participants84	Lead sponsorOther	StatusCompleted	Library tests named N-Back TaskSecondary3 weeks Go/No-Go TaskSecondary3 weeks Card Sorting Test (Berg)Secondary3 weeks Dot-Probe TaskSecondary8 weeks Attention Network TestSecondary8 weeks Affective Go/No-GoSecondary3 weeks
NCT03979404	Start2020	PhaseNot applicable	ConditionsOther conditions	Participants15	Lead sponsorOther	StatusStatus unknown	Library tests named Go/No-Go TaskSecondary4 weeks Dot-Probe TaskSecondary4 weeks Emotion Regulation TaskSecondary4 weeks Affective Go/No-GoSecondary4 weeks Food Choice TaskSecondary4 weeks
NCT03869463	Start2019	PhaseNot applicable	ConditionsDepression and bipolar disorder	Participants28	Lead sponsorOther	StatusStopped early	Library tests named Trail Making TestPrimary13 weeks Verbal LearningOther outcome13 weeks Verbal FluencyOther outcome13 weeks Digit Span TestOther outcome13 weeks Go/No-Go TaskPrimary8 weeks Symbol Scan TaskOther outcome13 weeks Affective Go/No-GoPrimary8 weeks

Questions, answered from the data

How many clinical trials use Affective Go/No-Go?

48 registered studies on ClinicalTrials.gov name it in an outcome measure, 18 of them in a primary outcome.

In which conditions do trials use Affective Go/No-Go?

Most often in depression and bipolar disorder (19), anxiety, PTSD and OCD (9) and healthy volunteers (6).

Do new trials use Affective Go/No-Go more or less?

0.2% of the studies that started in 2021 to 2025 name it, against 0.3% of those that started in 2016 to 2020: a share 23% smaller.

Which tests do trials use with Affective Go/No-Go?

The Go/No-Go Task (48 studies), the N-Back Task (8 studies) and Verbal Learning (6 studies).

When do trials measure Affective Go/No-Go?

Half of the primary outcomes that name Affective Go/No-Go are measured within 9 weeks of the start, and the middle half from 4 days to 5 months. 18 primary outcomes give a duration.

How many completed trials that use Affective Go/No-Go have reported results?

How the studies are counted

Run Affective Go/No-Go in your trial

Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.

Start free

Affective Go/No-Go in clinical trials: 48 registered studies

The conditions it is used in

How often it is a primary outcome

Studies by start year

Phases and study sizes

By phase

Participants per study

When trials measure it

Latest time point of each outcome

Status, results, interventions and countries

Status

What they test

Where their sites are

Reported results

Tests named in the same studies

Compared over time

Explore the 48 studies

Library tests named most

Conditions

Phases

Participants

The studies, newest registration first

Questions, answered from the data

How many clinical trials use Affective Go/No-Go?

In which conditions do trials use Affective Go/No-Go?

Do new trials use Affective Go/No-Go more or less?

Which tests do trials use with Affective Go/No-Go?

When do trials measure Affective Go/No-Go?

How many completed trials that use Affective Go/No-Go have reported results?

More on tests in clinical trials

How the studies are counted

Run Affective Go/No-Go in your trial

Affective Go/No-Go in clinical trials: 48 registered studies

The conditions it is used in

How often it is a primary outcome

Studies by start year

Phases and study sizes

By phase

Participants per study

When trials measure it

Latest time point of each outcome

Status, results, interventions and countries

Status

What they test

Where their sites are

Reported results

Tests named in the same studies

Compared over time

Explore the 48 studies

Library tests named most

Conditions

Phases

Participants

The studies, newest registration first

Questions, answered from the data

How many clinical trials use Affective Go/No-Go?

In which conditions do trials use Affective Go/No-Go?

Do new trials use Affective Go/No-Go more or less?

Which tests do trials use with Affective Go/No-Go?

When do trials measure Affective Go/No-Go?

How many completed trials that use Affective Go/No-Go have reported results?

More on tests in clinical trials

How the studies are counted

Run Affective Go/No-Go in your trial